Complete Filing Data
TuSimple Holdings Inc. reported Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax of -$1.34 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean TuSimple Holdings Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Net Income * | -$472.0M | -$732.7M | -$177.9M | -$84.8M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.3M | $378.0K | $401.0K | -$208.0K |
| Selling General And Administrative Expense | $127.1M | $118.1M | $38.6M | $22.8M |
| Revenue From Contract With Customer Excluding Assessed Tax | $9.4M | $6.3M | $1.8M | $710.0K |
| Research And Development Expense | $351.6M | $287.2M | $132.0M | $63.6M |
| Other Nonoperating Income Expense | $112.0K | -$168.0K | -$520.0K | $2.4M |
| Operating Income Loss | -$489.1M | -$411.4M | -$174.1M | -$87.3M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$472.0M | -$732.7M | -$177.9M | -$84.9M |
| Cost Of Revenue | $19.8M | $12.4M | $5.3M | $1.6M |
| Comprehensive Income Net Of Tax | -$475.7M | -$732.3M | -$177.5M | -$85.1M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | -$10.4M | -$6.1M | -$3.5M | -$885.0K |
| Operating Expenses | $478.7M | $405.2M | $170.6M | |
| Net Income Loss Available To Common Stockholders Basic | -$472.0M | -$736.8M | -$198.8M | -$145.0M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$2.3M | $0.00 | $0.00 | |
| Net Income Loss Available To Common Stockholders Diluted | -$472.0M | -$736.8M | -$198.8M | -$145.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$61.4M | -$78.0M | -$81.2M | -$113.2M | -$108.6M | -$111.9M | -$115.5M | -$116.5M | -$385.2M | -$89.5M | -$28.1M | -$25.8M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $1.5M | -$1.9M | $919.0K | -$1.3M | -$1.3M | $199.0K | -$73.0K | -$775.0K | $911.0K | $285.0K | $188.0K | $2.0K |
| Selling General And Administrative Expense | $26.3M | $28.7M | $28.7M | $31.1M | $22.0M | $32.2M | $29.7M | $43.5M | $15.9M | $459.0K | $243.0K | $437.0K |
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $92.0K | $215.0K | $2.7M | $2.6M | $2.3M | $1.8M | $1.5M | $944.0K | $584.0K | $263.0K | $259.0K |
| Research And Development Expense | $44.3M | $58.5M | $61.6M | $84.9M | $85.5M | $78.2M | $84.5M | $75.9M | $41.4M | $60.0M | $22.0M | $18.2M |
| Other Nonoperating Income Expense | -$77.0K | -$391.0K | -$507.0K | $127.0K | $207.0K | -$165.0K | $7.0K | $145.0K | $378.0K | -$116.0K | -$61.0K | $96.0K |
| Operating Income Loss | -$70.7M | -$87.4M | -$90.6M | -$118.8M | -$110.7M | -$112.2M | -$115.9M | -$120.9M | -$58.6M | -$76.5M | -$28.0M | -$25.9M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$61.4M | -$78.0M | -$81.2M | -$113.2M | -$108.6M | -$111.9M | -$115.5M | -$116.5M | -$385.2M | -$89.5M | -$28.1M | -$25.8M |
| Cost Of Revenue | $0.00 | $246.0K | $508.0K | $5.4M | $5.8M | $4.1M | $3.5M | $3.0M | $2.2M | $1.3M | $857.0K | $771.0K |
| Comprehensive Income Net Of Tax | -$59.5M | -$82.2M | -$79.9M | -$116.5M | -$109.9M | -$111.7M | -$115.6M | -$117.3M | -$384.2M | -$89.2M | -$27.9M | -$25.8M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Gross Profit | $0.00 | -$154.0K | -$293.0K | -$2.8M | -$3.2M | -$1.8M | -$1.7M | -$1.5M | -$1.3M | |||
| Operating Expenses | $70.7M | $87.2M | $90.3M | $116.1M | $107.5M | $110.4M | $114.2M | $119.4M | $57.3M | |||
| Net Income Loss Available To Common Stockholders Basic | -$113.2M | -$111.9M | -$115.5M | -$116.5M | -$389.3M | -$101.4M | -$28.1M | -$25.8M | ||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $512.0K | -$2.3M | $403.0K | -$2.1M | $0.00 | $0.00 | $0.00 | |||||
| Net Income Loss Available To Common Stockholders Diluted | -$113.2M | -$108.6M | -$111.9M | -$115.5M | -$116.5M | -$389.3M | -$101.4M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Stockholders Equity * | -$405.5M | -$219.4M | -$74.1M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $312.4M | $64.1M | $98.8M | ||
| Cash And Cash Equivalents At Carrying Value | $1.34B | $310.8M | $63.6M | ||
| Restricted Cash Current | $2.1M | $1.5M | $1.5M | $500.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$721.6M | $1.03B | $248.2M | -$34.7M | |
| Retained Earnings Accumulated Deficit | -$1.14B | -$405.2M | |||
| Prepaid Expense And Other Assets Current | $14.0M | $3.8M | |||
| Other Liabilities Noncurrent | $5.0M | $595.0K | |||
| Other Assets Noncurrent | $7.1M | $5.0M | |||
| Liabilities Current | $55.9M | $81.1M | |||
| Liabilities And Stockholders Equity | $1.40B | $346.6M | |||
| Liabilities | $69.3M | $87.3M | |||
| Common Stock Value | $22.0K | $6.0K | |||
| Assets Current | $1.35B | $319.5M | |||
| Assets | $1.40B | $346.6M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $77.0K | -$301.0K | |||
| Accrued Liabilities Current | $41.7M | $23.0M | |||
| Accounts Receivable Net Current | $1.6M | $1.1M | |||
| Accounts Payable Current | $4.5M | $4.5M | |||
| Finance Lease Principal Payments | $1.3M | $783.0K | $713.0K | $323.0K | |
| Temporary Equity Accretion To Redemption Value Adjustment | $0.00 | $4.1M | $21.0M | $201.0K | |
| Gains Losses On Extinguishment Of Debt | $0.00 | $4.2M | $0.00 | $0.00 | |
| Additional Paid In Capital Common Stock | $2.46B | $0.00 | |||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | ||||
| Repayments Of Related Party Debt | $0.00 | $4.4M | $7.9M | $146.0K | |
| Long Term Debt Noncurrent | $5.5M | $1.8M | |||
| Liabilities Assumed1 | $0.00 | $369.4M | $0.00 | $0.00 | |
| Accretion Of Redeemable Convertible Preferred Stock | $0.00 | $4.1M | $21.0M | $201.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $771.4M | $820.1M | $891.4M | $954.5M | $1.07B | $1.16B | $1.25B | $1.33B | $1.41B | $1.49B | -$787.5M | -$405.5M | -$364.9M | -$271.4M | -$243.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $250.9M | $316.4M | $512.0M | $617.5M | $873.0M | $1.16B | $1.24B | $1.34B | $1.41B | $1.49B | $509.5M | $69.7M | |||
| Cash And Cash Equivalents At Carrying Value | $249.2M | $314.7M | $510.0M | $615.4M | $871.4M | $1.16B | $1.24B | $1.41B | $1.49B | $508.7M | $68.9M | $21.6M | |||
| Restricted Cash Current | $1.7M | $1.7M | $2.0M | $1.6M | $1.5M | $1.5M | $1.5M | $1.5M | $785.0K | $750.0K | $750.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$105.5M | -$100.3M | $197.1M | -$23.8M | |||||||||||
| Retained Earnings Accumulated Deficit | -$1.83B | -$1.77B | -$1.69B | -$1.61B | -$1.47B | -$1.36B | -$1.25B | -$1.02B | -$906.9M | -$790.3M | |||||
| Prepaid Expense And Other Assets Current | $18.0M | $15.7M | $16.7M | $13.5M | $18.6M | $22.1M | $16.2M | $15.9M | $15.8M | $5.6M | |||||
| Other Liabilities Noncurrent | $12.0K | $11.0K | $824.0K | $2.4M | $6.0M | $4.1M | $4.3M | $5.8M | $3.7M | $3.7M | |||||
| Other Assets Noncurrent | $4.4M | $4.8M | $4.4M | $4.7M | $5.0M | $4.5M | $7.9M | $5.9M | $5.9M | $5.1M | |||||
| Liabilities Current | $37.2M | $48.0M | $50.8M | $71.5M | $59.5M | $47.9M | $42.2M | $46.1M | $38.2M | $45.8M | |||||
| Liabilities And Stockholders Equity | $848.5M | $909.6M | $986.9M | $1.07B | $1.18B | $1.26B | $1.34B | $1.47B | $1.54B | $548.4M | |||||
| Liabilities | $77.1M | $89.5M | $95.5M | $119.8M | $111.5M | $97.7M | $89.9M | $55.0M | $45.2M | $53.0M | |||||
| Common Stock Value | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $21.0K | $21.0K | $6.0K | |||||
| Assets Current | $793.2M | $849.7M | $924.0M | $1.01B | $1.09B | $1.18B | $1.26B | $1.43B | $1.51B | $520.3M | |||||
| Assets | $848.5M | $909.6M | $986.9M | $1.07B | $1.18B | $1.26B | $1.34B | $1.47B | $1.54B | $548.4M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$4.5M | -$6.4M | -$2.2M | -$3.6M | -$4.4M | -$1.1M | $276.0K | -$238.0K | -$165.0K | $610.0K | |||||
| Accrued Liabilities Current | $22.7M | $31.1M | $32.3M | $48.3M | $40.4M | $34.5M | $24.6M | $33.1M | $25.1M | $16.8M | |||||
| Accounts Receivable Net Current | $0.00 | $91.0K | $231.0K | $1.4M | $3.0M | $2.7M | $1.8M | $1.7M | $1.3M | $1.4M | |||||
| Accounts Payable Current | $3.7M | $5.8M | $6.6M | $9.9M | $6.7M | $3.7M | $3.4M | $4.4M | $5.1M | $13.8M | |||||
| Finance Lease Principal Payments | $217.0K | $293.0K | $0.00 | ||||||||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.1M | $11.9M | ||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $4.2M | $0.00 | ||||||||||
| Additional Paid In Capital Common Stock | $2.61B | $2.60B | $2.58B | $2.57B | $2.54B | $2.52B | $2.49B | $2.43B | $2.40B | $2.2M | |||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $1.28B | $664.8M | |||||||||||
| Repayments Of Related Party Debt | $0.00 | $613.0K | |||||||||||||
| Long Term Debt Noncurrent | $2.8M | $2.8M | $3.2M | $3.7M | $4.1M | $4.5M | $5.2M | ||||||||
| Liabilities Assumed1 | $0.00 | $369.4M | |||||||||||||
| Accretion Of Redeemable Convertible Preferred Stock | $0.00 | $4.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Depreciation Depletion And Amortization | $27.6M | $9.5M | $7.7M | $5.6M |
| Share Based Compensation | $98.7M | $122.6M | $12.8M | $0.00 |
| Payments To Acquire Intangible Assets | $296.0K | $416.0K | $306.0K | $161.0K |
| Net Cash Provided By Used In Operating Activities | -$329.9M | -$259.0M | -$103.8M | -$76.3M |
| Net Cash Provided By Used In Investing Activities | -$392.2M | -$13.6M | -$4.4M | -$10.4M |
| Net Cash Provided By Used In Financing Activities | $1.4M | $1.30B | $356.5M | $51.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.1M | $10.2M | -$274.0K | $1.5M |
| Increase Decrease In Other Operating Assets | -$2.6M | $1.8M | $682.0K | $941.0K |
| Increase Decrease In Other Noncurrent Liabilities | -$221.0K | -$7.0K | $296.0K | -$605.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $6.0M | $25.5M | $13.1M | $5.0M |
| Increase Decrease In Accounts Receivable | $213.0K | $497.0K | $1.0M | $116.0K |
| Increase Decrease In Accounts Payable | $6.5M | -$181.0K | $4.2M | $139.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$983.0K | $260.0K | $6.0K | $234.0K |
| Proceeds From Sale Of Property Plant And Equipment | $520.0K | $100.0K | $189.0K | $62.0K |
| Proceeds From Stock Options Exercised | $1.9M | $1.2M | $0.00 | $0.00 |
| Payments To Acquire Property Plant And Equipment | $13.6M | $13.3M | $4.3M | $10.3M |
| Proceeds From Warrant Exercises | $0.00 | $183.0M | $2.5M | $0.00 |
| Proceeds From Issuance Of Redeemable Convertible Preferred Stock | $0.00 | $54.7M | $291.6M | $52.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2023 | Q1 2022 | Q2 2021 | Q1 2021 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $1.6M | $2.7M | $2.3M | $2.1M | $1.8M | $1.8M |
| Share Based Compensation | $16.8M | $27.5M | $6.3M | $1.2M | ||
| Payments To Acquire Intangible Assets | $0.00 | $40.0K | $87.0K | $62.0K | ||
| Net Cash Provided By Used In Operating Activities | -$87.7M | -$100.6M | -$46.7M | -$22.4M | ||
| Net Cash Provided By Used In Investing Activities | -$18.1M | -$1.4M | -$1.2M | -$1.2M | ||
| Net Cash Provided By Used In Financing Activities | -$627.0K | $1.5M | $244.0M | -$171.0K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $3.2M | $422.0K | $3.4M | -$1.1M | ||
| Increase Decrease In Other Operating Assets | -$1.0M | $758.0K | $152.0K | $120.0K | ||
| Increase Decrease In Other Noncurrent Liabilities | $5.0K | $426.0K | $1.3M | $932.0K | ||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$18.2M | -$18.3M | -$8.2M | -$2.3M | ||
| Increase Decrease In Accounts Receivable | -$1.1M | $202.0K | $285.0K | $17.0K | ||
| Increase Decrease In Accounts Payable | -$3.0M | $227.0K | $9.2M | $1.1M | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $924.0K | $155.0K | $1.1M | -$42.0K | ||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $19.0K | $100.0K | |||
| Proceeds From Stock Options Exercised | $0.00 | $871.0K | $253.0K | |||
| Payments To Acquire Property Plant And Equipment | $680.0K | $1.4M | $1.2M | $1.1M | ||
| Proceeds From Warrant Exercises | $0.00 | $183.0M | ||||
| Proceeds From Issuance Of Redeemable Convertible Preferred Stock | $0.00 | $61.6M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Diluted EPS * | -$2.11 | -$4.36 | -$3.37 | -$2.47 |
| Weighted Average Number Of Shares Outstanding Basic | 224.2M | 169.1M | 58.9M | 58.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 224.2M | 169.1M | 58.9M | 58.7M |
| Earnings Per Share Basic | $-2.11 | $-4.36 | $-3.37 | $-2.47 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||
| Temporary Equity Shares Outstanding | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.27 | -$0.34 | -$0.36 | -$0.50 | -$0.49 | -$0.50 | -$0.54 | -$0.64 | -$6.43 | -$1.73 | -$0.49 | -$0.45 | ||
| Weighted Average Number Of Shares Outstanding Basic | 229.5M | 228.0M | 226.4M | 224.7M | 223.8M | 222.5M | 212.8M | 182.4M | 60.6M | 58.6M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 229.5M | 228.0M | 226.4M | 224.7M | 223.8M | 222.5M | 212.8M | 182.4M | 60.6M | 58.6M | ||||
| Earnings Per Share Basic | $-0.27 | $-0.34 | $-0.36 | $-0.50 | $-0.49 | $-0.50 | $-0.54 | $-0.64 | $-6.43 | $-1.73 | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 120.5M | 102.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $98.7M | $122.6M | $12.8M | |
| Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options | $168.0K | $84.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $1.9M | $911.0K | ||
| Fair Value Adjustment Of Warrants | $0.00 | $326.9M | -$1.8M | $0.00 |
| Interest Paid Net | $876.0K | $786.0K | $1.2M | $496.0K |
| Vesting Of Early Exercised Stock Options | $168.0K | $84.0K | $0.00 | $0.00 |
| Short Term Borrowings | $1.5M | $4.6M | ||
| Increase Decrease Due To Joint Development Partners | -$1.6M | $6.0M | $1.4M | $0.00 |
| Amounts Due To Joint Development Partners | $7.4M | $1.4M | ||
| Interest And Other Income | $16.9M | $1.6M | $454.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.8M | $11.0M | $16.8M | $23.0M | $25.2M | $27.5M | $32.1M | $52.5M | $6.3M | $7.6M | $453.0K | $1.2M | |
| Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | |||||||
| Stock Issued During Period Value Stock Options Exercised | $3.0K | $30.0K | $152.0K | $687.0K | $871.0K | $529.0K | $1.0K | ||||||
| Fair Value Adjustment Of Warrants | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $326.9M | $970.0K | ||||||
| Interest Paid Net | $158.0K | $281.0K | $195.0K | $173.0K | |||||||||
| Vesting Of Early Exercised Stock Options | $0.00 | $21.0K | $21.0K | ||||||||||
| Short Term Borrowings | $1.4M | $1.7M | $1.7M | $1.6M | $1.6M | $1.6M | $1.5M | $813.0K | $509.0K | $4.7M | |||
| Increase Decrease Due To Joint Development Partners | -$1.4M | $454.0K | $0.00 | ||||||||||
| Amounts Due To Joint Development Partners | $3.2M | $3.2M | $4.4M | $5.8M | $4.8M | $5.1M | $7.8M | $7.0M | $6.7M | ||||
| Interest And Other Income | $9.3M | $9.7M | $9.9M | $5.5M | $1.9M | $460.0K | $452.0K |
Most recent annual filing with the SEC: September 7, 2023
Data sourced from SEC EDGAR public filings as of August 5, 2026.